NEW YORK (GenomeWeb News) — GeneGo said yesterday that Aveo Pharmaceuticals has licensed its MetaCore 4.5 data-mining suite.
 
The latest version of the suite has disease enrichment and functional ontology functions, and is used to help target, select, and validate biomarkers.
 
The suite, which can concurrently visualize gene expression, proteomics, genetic, and metabolic data, has a management system that can be used to upload and handle thousands of genome-wide files, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.